Glaukos (GKOS) CFO executes pre-planned share sale and option exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Glaukos Corp SVP & Chief Financial Officer Alex R. Thurman reported an exercise-and-sale transaction in company stock. On July 6, 2026, he exercised stock options for 10,000 shares of common stock at $38.68 per share and, on the same date, sold 10,000 shares of common stock in an open-market transaction at $150.00 per share. After these transactions, he directly holds 43,681 shares of Glaukos common stock, in addition to 5,230 restricted stock units that are unvested. Both the sale and the option exercise were carried out under a Rule 10b5-1 trading plan adopted on December 15, 2025, indicating they were pre-arranged rather than opportunistic market trades.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 10,000 shares ($1,500,000)
Net Sell
3 txns
Insider
Thurman Alex R.
Role
SVP & CHIEF FINANCIAL OFFICER
Sold
10,000 shs ($1.50M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 10,000 | $38.68 | $387K |
| Exercise | Common Stock | 10,000 | $38.68 | $387K |
| Sale | Common Stock | 10,000 | $150.00 | $1.50M |
Holdings After Transaction:
Stock Option (Right to Buy) — 20,000 shares (Direct, null);
Common Stock — 53,681 shares (Direct, null)
Footnotes (1)
- Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
Key Figures
Shares sold: 10,000 shares
Sale price per share: $150.00 per share
Options exercised: 10,000 shares
+3 more
6 metrics
Shares sold
10,000 shares
Common stock sold in open-market transaction on July 6, 2026
Sale price per share
$150.00 per share
Price for 10,000 Glaukos common shares sold
Options exercised
10,000 shares
Stock options exercised into common stock on July 6, 2026
Option exercise price
$38.68 per share
Exercise price of stock options converted into common shares
Shares held after transactions
43,681 shares
Direct Glaukos common stock holdings following July 6, 2026 trades
Unvested RSUs
5,230 units
Restricted stock units not yet vested or delivered to the CFO
Key Terms
Rule 10b5-1 trading plan, restricted stock units, Stock Option (Right to Buy), vest over four years
4 terms
Rule 10b5-1 trading plan financial
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units financial
"Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) ... underlying security title: Common Stock."
vest over four years financial
"These options vest over four years from the grant date, with 25% vesting on the first anniversary."
FAQ
What insider transactions did Glaukos (GKOS) CFO Alex R. Thurman report?
Glaukos CFO Alex R. Thurman reported exercising options for 10,000 shares at $38.68 and selling 10,000 common shares at $150.00 on July 6, 2026, as part of a pre-arranged Rule 10b5-1 trading plan.
Was the Glaukos (GKOS) CFO’s July 2026 stock sale pre-planned under Rule 10b5-1?
Yes. Footnotes state the sale of 10,000 Glaukos shares and the related option exercise were effected under a Rule 10b5-1 trading plan adopted by Alex R. Thurman on December 15, 2025, indicating the trades were scheduled in advance.
What derivative securities were involved in the Glaukos (GKOS) CFO’s Form 4 filing?
The filing shows a stock option (right to buy) covering 10,000 underlying Glaukos common shares with an exercise price of $38.68. These options were exercised on July 6, 2026, consistent with a vesting schedule described in the footnotes.
How do the Glaukos (GKOS) CFO’s restricted stock units factor into his holdings?
Footnotes explain that Alex R. Thurman holds 5,230 restricted stock units that have not yet vested or been delivered. These RSUs represent potential future shares, subject to meeting service-based vesting conditions over the stated schedule.